Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: A myocardial contrast echocardiographic study  by Agati, Luciano et al.
336
uence of Residual Perfusion Withion the Infarct Zone
o the Natural History Left Ventricular Dysfunction After
Acute Myocardial Infarction: My
rdl'al Contrast
Echocardiographic Study
LUCIANO AGATI, MD, PAOLO VOCI, MD, PHD, FEDERICO BILO 1'A, MD,
ROBERTO LUONGO, MD, CAMILLO AUTORE, MD, MARIA PENCO, MD,
CARLO IACOBONI, MD, FRANCESCO FEDELE, MD, ARMANDO DAGIANTI, MD, FESC
Rome, Italy
` `ves . This study used myocardial contrast
Lbnited information is available on the status of
perlWon within hemle dystuactional segments
at predischarge and on its influence on late regional and global
hactiond recovery .
Me
	
. Twenty patients with acute my infarction
were selected for the study. nit the following inclusion
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Several clinical trials have provided convincing evidence
that thrombolytic therapy may improve the survival rate in
patients with acute myocardial infarction by limiting the
extent of infarct size (1-3) . Whereas the rate of improvement
in regional function seems to be related to the duration of
coronary occlusion, the degree of functional recovery is
related to the extent of necrosis (4,S) . Previous studies
comparing function before and after successful thrombolytic
therapy showed that contractile function recovery in the
salvaged tissue may require a long time ("stunned myocar-
dium") (6,7) . Although most of the improvement takes place
From the Department of Cardiology and Cardiac Surgery, La Sapienza
University of Rove, Rome, Italy
. This study was presented in part at the
Eighth Annual Meeting of the University of Chicago on Advances in 'Echo-
y, Chicago, Illinois, September 1993
.
Manuscript received December 8, 1993
; revised manuscript received
February 24, 1994, accepted March 11, 1994 .
Address for corresooodencg
: Dr
. Luciano Agati, Lungotevere Flaminio
60, Rom 00196, Italy.
01994 by the American College of Cardiology
JACC
Vol . 24, No . 2
August 1994 :336-42
the pattern of contrast enhancement in predischarge dysfunctional
segments .
Results. 1n nine patients (group 1), the length of segments
showing abnormal contraction coincided with that of the contrast
defect segments. In the remaining I I patients (group II), tisch-
emic dysfunctional segments were partly or completely reper-
re was no difference between the two groups in asyn-
segment length at ischarge (7 .3 t 2 .5 vs . 7 .2 t 4 .3 cm,
p = NS). At follow-up study, asynergic segment length was
ti
tly reduced in group II patients, whereas no changes
were observed in group I patients (from 7 .2 :t 4.3 to 4 .7 :t 3.7 cm,
p<0.005; and from 7.3t2.5to7
.5t2.9cm,p=NS,
respectively) .
Conclusions . Among patients with a predischarge patent
i t-related artery, further improvement in regional and global
function way be expected during follow-up when residual perfu-
sion in the infarct zone Is present .
(J Am Coll Cordial 1994;24.336-42)
within the tst 7 to 10 days after reperfusion (8-11), it is not
clear when it can be considered complete . Furthermore, the
exact amount of viable muscle necessary for functional
recovery after reperfusion therapy is not known .
Myocardial contrast echocardiography is a validated tech-
nique for the assessment of risk area soon after acute
myocardial infarction (12-15) . Moreover, recent studies (16-
19) have demonstrated that the extent of myocardial contrast
defect shortly after reperfusion in patients with myocardial
infarction is a strong predictor of the degree of short-term
functional recovery . However, limited information is avail-
able with regard to the status Vi myocardial perfusion in
dysfunctional segments before hospital discharge and its
influence on late functional recovery (20,21) .
This study therefore used myocardial contrast echocardi-
ography to investigate the extent of residual perfusion within
the infarct area in a select group of patients with recent
reperfused myocardial infarction and evaluated its influence
on the ultimate infarct size .
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Methods
Study patients . The study group included 20 patients (14
men, 6 women; mean [014 age 55 ± 6 years) admitted to
the coronary care unit with transmural acute myocardial
infarction diagnosed by a history of typical chest pain, ST
segment elevation >2 mm in two contiguous electrocardio-
graphic leads and a greater than threefold increase in serum
creatinine kinase (CK) level . Patients were prospectively
selected for this investigation if they met the following
inclusion criteria : 1) single-vessel coronary artery disease
without previous myocardial infarction or other cardiac
disease ; 2) patency of the infarct-related coronary artery
with complete anterograde perfusion (Thrombolysis in Myo-
cardial Infarction trial [TIAQ flow grade 3) (22) at predis-
charge coronary angiography ; 3) persistence of postischemic
dysfunctional segments before hospital discharge ; 4) stable
clinical condition with no major clinical events (death,
angina, reinfarction, coronary artery bypass graft surgery or
percutaneous transluminal coronary angioplasty) up to 6
months after hospital discharge ; and 4) technically adequate
echocardiographic studies allowing detection of the entire
left ventricular endocardiall contours during cardiac cathe-
terization . All patients were treated with intravenous throm-
bolytic therapy within 6 h from the onset of symptoms .
Twelve patients received tissue-type plasminogen activator,
and eight received urokinase, followed by heparin (infused
for 3 days and then administered subcutaneously until hos-
pital discharge) .
All patients underwent coronary angiography and myo-
cardial contrast echocardiography before hospital discharge
and repeated the echocardiographic examination 6 months
later (192 ± 21 days) .
Informed written consent was obtained from all patients
for both cardiac catheterization and contrast echocardiogra-
phy protocol. The protocol was approved by the La Sapi-
enza University of Rome Medical Ethical Committee .
Coronary artery cineangiography . Coronary angiography
was performed in all patients 10 ± 3 days after the onset of
acute myocardial infarction using the standard procedure
and equipment . The Judkins technique was used, and mul-
tiple projections, including cranial and caudal angulations,
were recorded at 30 framesls .
Coronary angiography disclosed a single atherosclerotic
lesion in the left anterior descending coronary artery in I I
patients, the left circumflex coronary artery in 7 and the right
coronary artery in the remaining 2 . No coronary collateral
flow was present at coronary angiography .
Measurement of residual coronary stenosis . Severity of
residual coronary narrowing after reperfusion was expressed
in terms of percent area stenosis. The best cineangiographic
images were selected and digitized by an array processor-
based computer for medical image processing (Mipron Sys-
tem, Kontron). For quantitative analysis of coronary artery
stenosis, a previously described and validated method
(23,24) was used .
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Myocardial contrast echocardiography. Myocardial con-
trast echocardiography was performed after routine predis-
charge coronary angiography, by manual injection of 0 .2 to
0.5 ml of sonicated 5% human serum albumin solution
separately into the right and left main coronary arteries . A
commercially available sonicating system was used (model
W-225; Beat Systems, Ultrasonics Corp .). The echo con-
trast agent was prepared under sterile conditions 1 h before
the study according to a previously described protocol
(24,25) . The echo contrast agent produced by this system
contained a concentration of 4 x 10' microbubbles/nil
(Coulter counter) with a diameter of 4 ± I um . Echocardio-
graphic images were recorded at held end-tidal respiration
on high fidelity videotape, from -10 s before the injection of
the contrast agent until the contrast enhancement was no
longer evident . Gain settings were optimized at the begin-
ning of each study and kept constant throughout the study .
Two-dimensional echocardiographic images were ob-
tained by a commercially available phased-array system
(Hewlett-Packard Sonos 10W) with a 3 .5-MHz transducer .
To allow better visualization of the left ventricle, a foam
wedge was placed behind the patient's back to tilt the chest
to a 30° left lateral position . Because of technical difficulties
in performing an adequate echocardiographic study from the
parasternal approach during cardiac catheterization, stan-
dard apical two- and four-chamber views were always re-
corded .
Data analysis. Apical views were analyzed to assess risk
area and regional wall motion abnormalities. For the study
design, only patients with adequate anterograde coronary
perfusion were selected ; hence, no collateral flow was
detected in our study group after contrast agent injection
separately into the right and left coronary arteries (26) • For
this reason, only images obtained after contrast agent injec-
tion into the infarct-related artery were used for analysis .
The apical view allowing the best visualization of postische-
mic dysfunctional segments was chosen for the predischarge
myocardial contrast echocardiographic study. The same
echocardiographic view was repeated during follow-up ex-
amination. Each of these studies was analyzed in blinded
manner by two experienced observers
. The risk area was
determined in the end-diastolic frame of the postinjection
cycle showing the best delineation between contrast-
enhanced and nonenhanced myocardium
. To quantify the
size of the risk area, the endocardial length of the contrast
defect (CD) segment was measured, as previously described
by Ito et al
. (17)
. Similarly, to assess the extent of postische-
mic abnormal contractile segment, the endocardial length of
the end-diastolic segment showing dyskinesia/akinesia
(no inward systolic endocardial motion) was measured
. The
relative change in asynergic segment length from predis-
charge (AS,) to the follow-up echocardiographic study (AS2)
was defined as J(ASZ - AS,)/AS,) x 100.
Patients were classified according to the pattern of con-
trast enhancement in predischarge dysfunctional segment by
the following formula
: (AS, - CD)/AS, . The presence or
,ACC Vol
. 24, No. 2
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Table t. Clinical, Angiographic and Echocardiographic Data
absence of coincidence between the length of segments
showing abnormal contraction and that with contrast defect
was the only criterion for patient classification .
Left ventricular volume was calculated by the area-length
method. Left ventricular ejection fraction was computed
according to the standard formula : [(End-diastolic volume -
End-systolic volume)/End-diastolic volume] x 100 . The rel-
alive change in left ventricular ejection fraction from predis-
charge (EF,) to follow-up (EF2) echocardiographic study (in
percent) was defined as [(EF2 - EFI)IEF 1] x 100 .
ut billty of myocardial contrast echocardiography
data. Reproducibility of measurements of the endocardial
length of contrast defect was assessed in five patients by
repeating intracoronary injections of sonicated albumin and
by measuring contrast enhancement in the same region
during both injections . Mean interinjection percent error was
4.2 ± 1 .60. Intraobserver and interobserver variability was
determined by measuring contrast defect in 10 injections
twice by the same observer and by two independent observ-
ers
. Mean percent intraobserver variability for contrast
defect length was 3 ± 1 .2% and mean percent interobserver
error was 4.8 ± 1 .8%. Intraobserver and interobserver
variability of the quantification of the asynergic segment
length was evaluated by measuring this variable in 10 pa-
AS, = asynergic segment length at predischarge-, AS, = asynergic segment length at follow-up ; CD = contrast defect ; EF, = ejection fraction at predischarge ;
EF 2 ejection fraction at follow-up
; IRA = infarct-related artery ; LAD = left anterior descending coronary artery ; LCx = left circumflex coronary artery ;
Pt - patient : RCA
-
right coronary artery .
tients twice by the same operator and by two experienced
operators. Mean percent intraobserver variability for asyn-
ergic segment length was 3 .9 ± 1 .5% and mean percent
interobserver error was 4 .4 ± 2.8% .
Statistical analysis. Data are expressed as mean value
SD. Data of the two groups at predischarge were compared
by one-way analysis of variance . Changes in the measured
variables during follow-up were estimated by one-way anal-
ysis of variance for repeated measures . When significant
differences were detected, individual mean values were
compared using post hoc tests . Correlation between relative
changes in asynergic segments length and ejection fraction
from predischarge to follow-up and the pattern of contrast
enhancement in predischarge dysfunctional segments was
performed by linear regression analysis ; p < 0.05 was
considered significant .
Results
In-hospital data. No patient had angina or other compli-
cations before hospital discharge (Table 1) . At predischarge,
€4 patients were in New York Heart Association functional
class 1 ; 3 in class 11 and the remaining 3 in class III .
In nine patients (group 1), the value for (AS, - CD)IAS I
Pt NoiGender
Age (yr) EF, EF
2 (EF2 - EF,)IEF,
AS, AS, CD (AS, - AS,)/AS, (AS, - CD)/AS,
IRA
Group I
11M
46 55 50
-9 .1 9 .1 9 .8
9
.1
7 .7 0.00 RCA
21F 64
40 35
-12 .5 7 .8 8 .2
7
.8
5 .1 0.00 LAD
31F 70 55
55 0 .0
6 .9 6 .9 6 .9 0 .0 0.00
LAD
41M 59
55 55
0 .0 4 .9 4 .9 4 .9 0 .0
0.00 LCx
51M 55
40 45
12 .5 9 .8 9 .7 9 .8 -1 .0
0.00 LCx
6fF
63 60 65
8 .3 8 .2 7 .9
8
.2 -3 .7
0.00 RCA
71M
44 65 65
0 .0 4 .2
4
.2
4 .1 0 .0 0.02 LAD
81M 60 35 35
0 .0 10 .7 12 .5
10 .5 16.8 0.02 LAD
9/M 63
70 70 U .0
3 .8 3 .8 3 .5 0 .0 0.08 LCx
Mean 58 .22
52.8 52 .8 -0 .1
7 .3 7 .5 7 .2 2 .8 ().III
SD 8
.54 12.0 12 .8
7
.6
2 .5 2 .9
2 .5
6 .3 0.03
Group II
101F
64 50 60 20
.0 6 .3 5 .1 4 .7 -19 .0 0.25 LAD
111M
56 30 40 33
.3 15 .2 10 .4 9 .1 -31 .6 0.40 LAD
121M 52 30 35
16 .7 13 .5 10 .8 7 .0 -20 .0 0.48 LCx
131M 50 55
61) 9 .1 9 .5 7 .3 4 .5 -23 .2 0.53 LCx
14/M 56 35
50 42 .9 9 .7 6 .3 4 .2 -35
.1 0.57
LAD
IS/F 52
50 60 20 .0
6 .2 4 .1 2 .4 -33 .9 0.61 LAD
161M 50 55 60 9 .1
4 .9
2 .9
0.0 -40 .8 1 .00 LCx
17/M 56 60 60 0 .0
4 .7 2 .6 0.0 --44 .7 1 .00 LCx
181M 52 55 65 18 .2 4 .2
2
.6
0 .0 -38 .1 1 .00 LAD
19/F 50 60
75 25 .0 3 .6 0 .0 0 .0 -100 .0 1 .00 LAD
201M 53 70
70 0 .0 1 .5 0.0 0.0 -109 .0 1 .00 LAD
Mean 53 .7 50.0 57 .7 17 .7
7
.2 4 .7 2.9
-44
.2
0.71
SD 4 .1 13 .0 11 .9 13 .1
4
.3 3 .7 3 2 28 .8
0.29
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Figure I . Bar graph showing asynergic
segment length changes from predischarge
to follow-up in group I and II patients .
There was no difference in asynergic seg-
ment length at baseline between the two
groups. At follow-up, asynergic segment
length was significantly reduced in group
II patients with residual perfusion in the
infarct area ; no changes were observed in
group I patients .
Figure 2. Bar graph showing ejection
fraction changes from predischarge to
follow-up in group I and II patients . There
was no difference in ejection fraction at
baseline between the two groups . Patients
with residual perfusion in the infarct area
(group 11) showed an improvement in this
variable from predischarge to follow-up .
Conversely, ejection fraction remained
unchanged in group I patients .
E
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6
4
0
was 0.01 ± 0 .03 (range 0 to 0.09), suggesting that the length
of segments showing abnormal contraction coincided with
that of the contrast defect segment . In the remaining I I
patients (group II), this value was 0 .71 ± 0 .29 (range 0 .25 to
1 .00). In these patients, a contrast effect was observed at the
edges of the ischemic area, suggesting that normally per-
fused but dysfunctioning segments were present at the
lateral borders of the damaged myocardium . Consequently,
the extent of contrast defect was significantly less in group 11
patients (7 .2 ± 2.5 vs . 2.9 = 3 .2, p < 0.005) . The perfusion
boundary was somewhat irregular. However, contrast en-
hancement was never observed within the body of the
ischemic area . Thus, regions with any degree of contrast
enhancement were clearly distinguished from those with no
contrast enhancement .
The two groups were similar with regard to mean age
(58 ± 8 vs . 53 ± 4 years, p = NS), asynergic segment length at
predischarge (7.3 ± 2.5 vs . 7 .2 ± 4.3 cin, p = NS), mean CIA
and CK-MB fraction levels (490 58 vs. 510 ± 64 Ulliter,
p =: NS ; 15 qm 3 vs. 17 ± 2%, p NS, respectively), length
of time from onset of symptoms to initiation of thrombolytic
® a0
20
10
0
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therapy (3 .5 ± 0 .9 vs. 3 .2 ± 1 .7, p = NS) and percent
residual coronary artery stenosis after reperfusion (48
± 15
vs. 51 ± 13%, p = NS) .
Follow-up data. At follow-up study, asynergic segment
length was significantly reduced in group II patients,
whereas no changes were observed - in group I patients (from
7 .2 ± 4 .3 to 4.7 ± 3.7 crrp < U05 ; from 7 .3 ± 2 .5 to 7.5 ±
2.9 cm, p = NS, respectively) (Table 1, Fig . 1) . An expan-
sion of the asynergic segment was detected in three group I
patients .
There was also no difference in ejection fraction at
baseline study between the two groups (52 .8 ± 12% vs . 50 ±
13%, p = NS). However, patients with residual perfusion in
the infarct area showed improvement in this variable from
predischarge to follow-up (from 50 -t 13% to 57 .7 ± 11%,
p < 0.0001). Conversely, ejection fraction remained un-
changed in group I (from 52 .8 ± 1211 to 52 .8 J: 12%, p n= NS)
(Fig. 2) .
Finally, a close relation was found between the relative
change in asynergic segment length from predischarge to
follow-up and the pattern of contrast enhancement in pre-
NS
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Flpre 3. Graph showing relation -20.oo
between the relative change in
asynergic segment length from !~
predischarge (AS[) to follow-up
:
-*LOO
(AS2) and the length of contrast
defect :D) in predischarge dys-
functiunal segments (AS I). A
close correlation exists between
these two variables, .woo .
4
n
V
.rt60 .od 1
discharge dysfunctioning segments: y
-
3.69 - 67-lx
(r = -0.87, SEE = 16 .2, p < 0.0001) (Fig . 3); only a weak
correlation was found between ejection fraction changes and
extent of reperfusion within the infarct area : y = 4.4 + 13 . Ix
(r = 0.39, SEE = 13.0, p < 0 .0<9).
D scussiion
Recently, Ito et al . (16,17) demonstrated that evaluation
of the extent of myocardial contrast defect soon after reper-
fusion is a strong predictor of the degree of short-term
functional recovery of the postischemic myocardium . The
extent of contrast defect is strictly dependent on the magni-
tude of collateral vessel-derived residual blood flow and on
the prompt achievement of coronary reflow throughout the
infarct-related artery (16-19,26). These data have been re-
cently confirmed by Clements et al. (27), who showed that
the presence of antero a or collateral flow to the infarct
zone before direct angioplasty in acute evolving infarction
results in a smaller infarct size after angioplasty, However,
less attention has been given to the status of myocardial
perfusion within postischemic dysfunctional segments at
predischarge.
The present study further confirms that myocardial con-
trast echocardiography is very useful in assessing tissue
viability after acute myocardial infarction (16-19) and that
knowledge of the status of myocardial perfusion before
hospital discharge may add useful clinical and prognostic
information .
The coincidence between the length of segments showing
abnormal contraction with that of the contrast defect seg-
ments identifies the definitive infarct size without further
improvement in left ventricular regional and global function
during follow-up. Thus, this pattern characterizes a subset of
patients who have contractile abnormalities that are irrevers-
ible, and no further reduction in infarct size can be expected
after hospital discharge . However, the presence of residual
perfusion in the dysfunctional segments may be followed by
0.40 0.50 0.60 0.70 0.0 9 .00
a
IASI-CI)/ASI
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a further reduction in infarct size after hospital discharge, with
a slight but significant increase in global left ventricular func-
tion (Fig. 4). Thus, the natural history of regional dysfunc-
tion after effective coronary reperfusion in patients with
single-vessel coronary artery disease and without clinical
Figure 4. Two-dimensional echocardiograms (four-chamber view) at
end-diastole (a) and end-systole (b) at predischarge and at follow-up
control (c and d, respectively) in a patient with reperfused anterior
myocardial infarction. At predischarge, the middle portion of the
interventricular septum and the apex were akinetic. A residual
perfusion in the middle portion of the interventricular septum was
identified by myocardial contrast echocardiography (a and b) . The
presence of residual perfusion into the dysfunctional segments
before hospital discharge was followed by a reduction in the infarct
size 6 months later (c and d) . LV = left ventricle .
JACC Val . 24, No
. 2
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evidence of restenosis during follow up is strongly influenced
by the status of residual perfusion in the infarct zone .
It has been shown (28,29) that among patients surviving
Q wave acute myocardial infarction, the long-term clinical
outcome in those with a patent
infarct-related artery is more
benign than that observed in patients without coronary
reflow. This study provides new information showing that
among patients with a predischarge patent infarct-related
artery, further improvement in regional and global function
can be expected when residual perfusion in the infarct zone
is present . The presence of normally perfused dysfunctional
regions at the lateral borders of the damaged myocardium
has been recently detected with myocardial contrast echo-
cardiography by Nanto et al . (30) during acute and transient
myocardial ischemia. Our data showed that a "functional
border zone" at the lateral margins of the ischemic area can
also be identified by myocardial contrast echocardiography
in patients with recent myocardial infarction, suggesting that
the extent of wall motion abnormalities at predischarge may
overestimate the extent of the definitive infarct size .
A close relation was found between the relative change in
asynergic segment length from predischarge to follow-up and
the pattern of contrast enhancement in predischarge dys-
functional segments . Conversely, only a weak correlation
was found between ejection fraction changes and the extent
of reperfusion within the infarct area . These data further
confirm that regional indexes of left ventricular function are
more sensitive than global indexes in evaluating the extent of
salvage and the severity of regional stunning after reperfu-
sion (31) .
Time course of functional recovery after coronary reperfu-
sion. Several studies in patients with recent myocardial
infarction have shown that functional improdcrnent takes
place largely within the 1st 7 to 10 days after reperfusion
(7-1[,16,17) . However, experimental and clinical studies
have found a further, late recovery of regional left ventric-
ular function after acute myocardial infarction (29,31-36) .
Our results confirm that a further reduction in postischemic
regional myocardial dysfunction may be observed 6 months
after acute myocardial infarction. This functional improve-
ment was mainly related to the presence of residual myocar-
dial perfusion in predischarge dysfunctional segments . Our
data are consistent with the hypothesis that in some cases
myocardial stunning may persist >10 days after coronary
reperfusion (31,35) . The "stunned" myocardium needs time
to repair damaged metabolic processes and to reconstitute
high energy phosphate stores . Alternatively, the delayed
recovery of left ventricular regional function after reperfu-
sion may be explained by the presence of a high grade,
flow-limiting residual stenosis that could cause persistent
subendocardial ischemia, or "hibernation" (31) . In the days
after administration of thrombolytic therapy, gradual lysis of
the thrombus or remodeling of the plaque, or both, could
lessen the severity of the stenosis and bring about a gradual
increase in subendocardial flow, thereby resulting in slow
functional recovery (31). In this study, only patients with
complete anterograde coronary perfusion at predischarge
were selected . However, coronary angiography was not per-
formed soon after thrombolytic therapy . Thi ., s, even though
all selected patients underwent thrombolytic therapy within
6 h from the onset of symptoms, the exact time of complete
coronary reflow is not known . Therefore, both of these
mechanisms may be responsible for the delayed functional
recovery observed in this study .
Study limitations. Serial echocardiographic control stud-
ies between predischarge and follow-up were not performed .
Thus, the exact time of the ultimate infarct size cannot be
identified by this study .
Coronary angiography was not performed at follow-up .
Thus, although all patients selected were in stable clinical
condition, with no major clinical events up to 6 months after
hospital discharge, the expansion in infarct size observed
during follow-up in three group l patients may be due to a
late asymptomatic coronary reocclusion (11,37) .
A no-reflow phenomenon cannot he demonstrated in the
present study . For this purpose, imaging the heart days after
reperfusion might be not useful (38) . However, experimental
data have described an increase in the size of the no-reflow
zone with time, after the moment of reperfusion (39) . Thus,
the size of contrast defect observed at predischarge, despite
infarct-related artery patency, might represent the definitive
extent of the no-reflow area . More myocardial contrast echo-
cardiographic studies are needed to compare admission and
predischarge contrast defects and to better understand
whether the no-reflow state worsens over time in humans
(40).
Clinical implications. Previcus studies (16,17) demon-
strated the usefulness of contrast echocardiography in the
evaluation of myocardial reflow by performing coronary
angiography in the first hours after acute myocardial infarc-
tion. The present study shows that in patients surviving
acute myocardial infarction, the predischarge analysis of
ratio between myocardial contrast defect and dysfunctional
segments is a simple and useful method to better distinguish
still viable from necrotic myocardial regions, This analysis
provides new insights into the influence of residual perfusion
in the infarct area on the natural course of left ventricular
remodeling after acute myocardial infarction . The presence
of residual perfrsion in the infarct zone may prevent infarct
expansion and may allow further late reduction in the
ultimate infarctt size . Thus, all efforts to maintain a patent
infarct-related artery and to prevent coronary reocclusion
are justified .
We thank Paola Luciolli for expert assistance in the preparation of the
manuscript and Sabino Scilimati for technical assistance .
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